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The lamin B receptor (LBR) is an inner nuclear membrane protein with a structural function interacting with chromatin and 
lamins, and an enzymatic function as a sterol reductase. Heterozygous LBR mutations cause nuclear hyposegmentation 
in neutrophils (Pelger anomaly), while homozygous mutations cause prenatal death with skeletal defects and abnormal 
sterol metabolism (Greenberg dysplasia). It has remained unclear whether the lethality in Greenberg dysplasia is due to 
cholesterol defects or altered nuclear morphology.
To answer this question we characterized two LBR missense mutations and showed that they cause Greenberg dys-
plasia. Both mutations affect residues that are evolutionary conserved among sterol reductases. In contrast to wildtype 
LBR, both mutations failed to rescue C14 sterol reductase deficient yeast, indicating an enzymatic defect. We found no 
Pelger anomaly in the carrier parent excluding marked effects on nuclear structure. We studied Lbr in mouse embryos 
and demonstrate expression in skin and the developing skeletal system consistent with sites of histological changes in 
Greenberg dysplasia. Unexpectedly we found in disease-relevant cell types not only nuclear but also cytoplasmatic LBR 
localization. The cytoplasmatic LBR staining co-localized with ER-markers and is thus consistent with the sites of endo-
geneous sterol synthesis.
We conclude that LBR missense mutations can abolish sterol reductase activity, causing lethal Greenberg dysplasia 
but not Pelger anomaly. The findings separate the metabolic from the structural function and indicate that the sterol 
reductase activity is essential for human intrauterine development.
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Results
We studied three fetuses that all fulfilled the clinical criteria 
of Greenberg dysplasia, namely intrauterine growth retardation, 
massive generalized edema (hydrops), extreme shortening of 
long bones (tetrabrachymelia) with a moth-eaten appearance of 
tubular bones, ectopic calcification centers and a narrow thorax 
(Fig. 1A, Suppl. Table 1). Detailed clinical examination was 
obtained from fetus A; fetus B has been described previously.25 
Sterol analyses were performed in muscle tissue of fetus B 
and revealed the abnormal sterol metabolite 5α-cholest-8,14-
dien-3β-ol,25 that was previously shown to be associated with 
Greenberg dysplasia.18 Sterol analysis was not available for the 
other two fetuses.
Sequence analysis revealed frameshift and missense muta-
tions in the LBR gene. We sequenced LBR and identified 
mutations in all three families (Fig. 1B, sequence traces and 
segregation in Suppl. Fig. 1A). Fetus A showed a homozygous 
frameshift mutation c.1492delT that is predicted to change resi-
dues 468 to 474 and to create a premature stop in codon 475 
(p.Y468TfsX475). Fetus B revealed two different mutations, 
c.32delTGGT and c.1748G>A. The first is a deletion of 4 base 
pairs causing a frame shift with subsequent premature stop 
in codon 24 (p.V11EfsX24). The second is a missense muta-
tion replacing arginine by glutamine at residue 583 (R583Q). 
Both parents of fetus C were carriers of the missense mutation 
p.N547D. Even though no material was available from fetus C to 
show homozygosity for mutation p.N547D, consanguinity of the 
parents and the presence of the same mutation in another fetus 
with Greenberg dysplasia28 indicate that this mutation was caus-
ative. We proved that the nucleotide changes were not present in 
150 controls, thereby making a polymorphism unlikely. For the 
missense mutations, we tested another 150 controls, to further 
reduce the possibility that they were rare variants.
The missense mutations reside in the sterol reductase domain 
and affect evolutionary conserved residues (Fig. 1B). We tested 
the potential relevance of the identified missense mutations by 
an interspecies comparison. The p.N547D and p.R583Q muta-
tions both change residues that are evolutionary extremely con-
served among LBR and other sterol reductases, indicating their 
functional relevance (Suppl. Fig. 1B). Sequencing of DHCR7 and 
TM7SF2 did not reveal alterations in any of the families, exclud-
ing a second hit in another gene of the C14 sterol reductase family.
LBR missense mutation did not alter nuclear shape in 
neutrophils. Since both missense mutations reside in the ste-
rol reductase domain of the lamin B receptor, disruption of the 
sterol reductase function seemed likely. However, the position 
of these mutations made effects on the second function of the 
lamin B receptor, namely nuclear structure, less likely. Based 
on the assumption that the amino acid substitution does not 
affect essential regions for modification, transport, or lamin B 
receptor anchoring, we expected nuclear morphology to remain 
unchanged. To test this hypothesis, we obtained blood from the 
parents of fetus B. The blood smear of the father indeed showed 
apparently normal neutrophils with multisegmented nuclei, 
whereas the mother had an obvious heterozygous Pelger anomaly 
Introduction
The lamin B receptor (LBR) is a multifunctional inner nuclear 
membrane protein with structural impact on nuclear shape 
and chromatin organization.1 The nucleoplasmatic part 
directly and indirectly interacts with chromatin, lamins, het-
erochromatin proteins HP1α and γ, histones H3 and H4 and 
other nuclear components.2,3 The transmembrane part belongs 
to the sterol reductase family and exhibits sterol reductase 
activity in vivo.4-7
LBR and lamins contribute to chromosome positioning, 
gene expression and distribution of nuclear pore complexes. 
Also, the lamin network has been shown to be involved in other 
essential cellular processes such as mitosis, meiosis and apopto-
sis. Laminopathies are diseases associated with lamin network 
proteins. Alterations of nuclear envelope components such as 
emerin or lamin A/C change nuclear shape and cause a variety 
of human diseases. Manifestations range from developmental to 
degenerative phenotypes, including cardiomyopathy, restrictive 
dermatopathy, lipodystrophy, mandibuloacral dysplasia, mus-
cular dystrophy, peripheral neuropathy and premature ageing 
syndromes.8-14 This demonstrates the essential cellular and clini-
cal impact of the lamin network.
Lamin B receptor mutations cause human Pelger anomaly 
(Pelger-Huët anomaly, PHA [MIM 169400]), human lethal 
Greenberg dysplasia (HEM [MIM 215140]), and recessive ich-
thyosis in mice (ic/ic). We showed earlier that LBR mutations 
cause dose-dependent hyposegmentation of granulocyte nuclei 
in individuals with heterozygous or homozygous Pelger anoma-
ly.15 Heterozygous LBR mutations alter neutrophil morphology 
without causing disease, while homozygous LBR mutations 
cause a spectrum of systemic malformations ranging from car-
diac defects, brachydactyly and mental retardation (as occurs in 
homozygous Pelger anomaly), to severe skin disease (modeled by 
ichthyotic ic/ic mice) and prenatal death, as found in Greenberg 
dysplasia.15-18
Greenberg dysplasia is also known as HEM skeletal dys-
plasia, an abbreviation derived from the characteristic fea-
tures hydrops, ectopic calcification and moth-eaten skeletal 
dysplasia.18-25 The disease is associated with an abnormal ste-
rol metabolite, cholesta-8,14-dien-3β-ol. Defects in other 
sterol synthesis enzymes present with skeletal malformations, 
mental retardation, failure to thrive or even death, and are 
viewed as metabolic malformation syndromes.26 Whereas some 
groups believe that in Greenberg dysplasia the sterol defect is 
causative,18,26 others assume the primary problem in altered 
nuclear structure.27
So far, truncating mutations, namely nonsense, splice site and 
frameshift mutations, have been reported for Pelger anomaly.15-17 
For Greenberg dysplasia, one homozygous nonsense mutation 
and one homozygous missense mutation in the lamin B receptor 
gene were described.18,28 In the family with Greenberg dyspla-
sia due to homozygous missense mutation p.N547D, no sterol 
measurements or blood smears were available.28 It thus remained 
unclear whether or not the lethal effect is due to altered sterol 
metabolism or due to altered nuclear structure.28,29
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Both missense mutations failed to compensate for C14 ste-
rol reductase deficiency in yeast. The human wildtype lamin 
B receptor can complement for the sterol reductase function in 
yeast.5,30 LBR belongs to the C14 sterol reductase family as does 
yeast ERG24. The ERG24 deficient yeast has an altered sterol 
metabolism where the normal end product, ergosterol, is  missing 
and the abnormal metabolite ignosterol is produced instead. 
with nuclear hyposegmentation (Fig. 2). This state of affairs was 
confirmed by sequence analyses. The mother with the Pelger 
anomaly was the carrier of the nonsense mutation p.V11EfsX24. 
The father, with the normal neutrophils on blood smears, carried 
the heterozygous missense mutation p.R583Q, indicating that 
this mutation affects sterol metabolism but not nuclear shape. No 
blood smears from the parents of fetus A and C were available.
Figure 1. Phenotype and identified mutations. (A) Post mortem appearance of fetus A at 16 + 3 weeks pregnancy. Note the edema, extreme microme-
lia of all four limbs and roentgenographic moth-eaten appearance of tubular bones. The thorax is deformed and narrow. Note the large head with hy-
groma and the hexadactyly on hands and feet. Scale bar 1 cm. (B) Schematic view of the lamin B receptor as a protein of the inner nuclear membrane 
and identified mutations. The nucleoplasmatic part interacts directly and indirectly with lamins, chromatin and other nuclear proteins. The transmem-
brane domain belongs to the C14 sterol reductase family and displays sterol reductase activity. The missense mutations p.N547D and p.R583Q reside 
in the transmembrane domain (sterol reductase domain). The two frameshift mutations are predicted to create a premature stop codon and thus the 
RNA is likely to undergo nonsense mediated decay, abolishing both the structural and metabolic function. Missense mutation p.N547D was previously 
described.28
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in an amount similar to the wildtype 
rescue, indicating a partial compen-
sation. However, p.N547D caused a 
significant accumulation of the abnor-
mal metabolites 4-methylzymosterol 
and ignosterol. Human mutation 
p.R583Q failed to produce the normal 
end product ergosterol in significant 
amounts. Instead, we observed a huge 
accumulation of the abnormal end 
product ignosterol. Both mutations 
increased the total amount of pathway 
metabolites, probably to provide at 
least trace amounts of ergosterol that 
is necessary for a number of essential 
cellular functions in yeast. Analyses of 
growth pattern confirmed these results 
with p.N547D partially restoring 
growth and p.R583Q failing to do so 
(Fig. 3C).
In fibroblasts, LBR is not only 
located at the nuclear rim but also 
shows significant non-nuclear local-
ization. The lamin B receptor is a pro-
tein of the inner nuclear membrane. 
Accordingly predominant localization 
was so far only reported in the nucleus. 
To test the hypothesis that malforma-
tions observed in Greenberg dysplasia 
result from effects other than nuclear 
sterol synthesis, we studied the cellular 
distribution of the protein. The abnor-
mal sterol metabolite in Greenberg 
dysplasia was initially identified by 
growing Greenberg fetal fibroblasts in 
lipid-depleted serum.18 We therefore 
reasoned that fibroblasts are a reason-
able cell type to test this hypothesis 
and indeed found extensive localiza-
tion of the lamin B receptor outside 
the nucleus (Fig. 4A and B). De-novo 
endogeneous sterol synthesis takes 
place in the endoplasmatic reticulum 
(ER). Accordingly, we found a co-localization of the non-nuclear 
LBR with calnexin as an ER membrane component (representa-
tive localization in Fig. 4A; more cells are shown in Suppl. Fig. 
3). Further, we tested this in HeLa cells that have a higher growth 
rate and a higher expression level of LBR compared to fibroblasts. 
We found extensive cytoplasmic localization of LBR co-localizing 
with calnexin in immunostaining also in this cell type. Further, 
the western blot of fractionated HeLa cells revealed LBR in both 
the nuclear and cytoplasmic fraction whereas the nuclear marker 
lamin B was only present in the nuclear fraction (Suppl. Fig. 4).
LBR is expressed in human osteoclasts and osteoblast-like 
cells. The Greenberg phenotype manifests as hydrops and severe 
skeletal dysplasia with shortening of long bones and altered 
Since ergosterol is essential, ERG24 mutants show impaired 
growth (Fig. 3A, Suppl. Fig. 2).
We first demonstrated that wildtype human LBR and wild-
type yeast ERG24 rescued the ERG24 deficient yeast phenotype 
in our system (data not shown). We then introduced the missense 
mutations p.N547D and p.R583Q, respectively, and transformed 
yeast with these mutant variants. We found that the mutants 
failed to rescue the yeast ergosterol phenotype (Fig. 3B). As 
expected, wildtype yeast showed metabolites of the normal path-
way, lanosterol, fecosterol and ergosterol. The same applied for 
ERG24 deficient yeast rescued by transformation with the yeast 
ERG24 gene or by the human LBR wildtype gene. The human 
LBR mutant p.N547D also produced fecosterol and ergosterol 
Figure 2. Neutrophils show normal nuclei with multiple segments in the father with heterozygous 
missense mutation p.R583Q and in controls, indicating that this mutation does not affect nuclear 
shape. In contrast, the mother is a heterozygous carrier of a nonsense mutation and shows Pelger 
anomaly with hypolobulated nuclei in blood smears. Five representative neutrophils per individual 
are shown. Scale bar 10 µm.
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addition to the cartilage/bone expression, a signal for Lbr pro-
tein was also observed in muscle and in connective tissue fibro-
blasts. Consistent with the findings in human fibroblast cultures, 
we found, in addition to localization at the nuclear rim, a non-
nuclear staining in connective tissue  fibroblasts and also in Lbr-
expressing cells of the developing cartilage and bone (Fig. 6A and 
magnification in B).
growth plates in early fetal develop-
ment. Therefore, we analyzed RNA 
levels in potentially disease-relevant 
human cell lines. We found expres-
sion of LBR in fibroblasts, lympho-
blastoid cells, and to a very high 
degree in human in vitro differen-
tiated osteoclasts (OC) and human 
osteosarcoma cells (HOS) which are 
osteoblast-like (Fig. 5A).
LBR is strongly expressed in 
liver, skin, brain as well as in spe-
cific regions of the developing car-
tilage and bone in mouse embryos. 
To analyze Lbr expression in vivo 
we studied wildtype mouse embryos 
at developmental stages consistent 
with the earliest manifestations in 
human Greenberg fetuses which 
have been reported as early as in gw 
13 by ultrasound. In situ hybridiza-
tion in wildtype mouse embryos at 
embryonic day E12.5 (correspond-
ing to human gw 8 + 2) and qPCR 
of mouse tissues at postnatal day P4 
showed strong expression of Lbr-
RNA in the liver, lung, midgut, 
skin, brain, as well as in developing cartilage (Fig. 5B and C). 
To further analyze Lbr expression in growth plate cartilage we 
performed immunohistochemistry on E15.5 mouse forelimb sec-
tions in comparison to the chondrogenic marker Sox9 (Fig. 6A). 
Lbr is expressed throughout growth plate cartilage, with weaker 
expression in hypertrophic chondrocytes. At the sites of trabecu-
lar bone formation Lbr expression was also seen in osteoblasts. In 
Figure 3. Design and results of the 
yeast rescue experiment. (A) System-
atic view of the rescue experiment.  
(B) Analysis of human LBR constructs 
by GC/MS. hLBRwt is able to comple-
ment ERG24 deficiency in yeast. hLBR_
N547D is partially able to comple-
ment ERG24 deficiency, visible in the 
production of the end product of the 
sterol pathway, ergosterol. However, 
providing this essential component 
happens on the cost of also produc-
ing large amounts of the abnormal 
metabolites 4-methylzymosterol and 
ignosterol. hLBR_R583Q is not able to 
complement ERG24 deficiency, seen 
in the insufficient production of the 
normal endproduct ergosterol and 
massive accumulation of the irregular 
product ignosterol. (C) Growth pat-
tern. Mutation p.R583Q failed to nor-
malize the growth of Erg24 deficient 
yeast. Mutation p.N547D partially 
compensated for Erg24 deficiency 
with respect to growth.
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enzymopathy and a structural trait by mutations 
in the same gene product is, as to our knowledge, 
quite unique. We draw attention to the dominant 
structural effect in Pelger anomaly and the reces-
sive enzymopathy in Greenberg dysplasia.
The N-terminal part mediates the interaction 
of the lamin B receptor with lamins, chromatin 
and heterochromatin proteins.2,4,31 Nonsense 
mutations with subsequent loss of the encoded 
protein impair that structural function and result 
in hyposegmentation of neutrophil nuclei and 
altered chromatin structure, as seen in the Pelger 
blood phenotype in the mother with the het-
erozygous nonsense mutation p.V11EfsX24. In 
contrast, the nuclear structure of neutrophils was 
unaffected by missense mutation p.R583Q which 
affects a residue of the sterol reductase domain 
only. The father of fetus B was heterozygous for 
missense mutation p.R583Q and did not show 
any evidence for Pelger anomaly. We assume that 
the nuclear structure is also not markedly altered 
in other cell types since the nuclei of neutrophils 
are especially sensitive to loss of LBR. In addi-
tion, the position of this mutation within the 
membrane makes a marked structural effect on 
nuclear shape unlikely. The same applies for mis-
sense mutation p.N547D where no blood smears 
from the parents were available.
In contrast, both missense mutations failed 
to compensate for C14 sterol reductase defi-
ciency in yeast, indicating severe enzymatic 
defects in sterol metabolism. We showed that 
both missense mutations affect evolutionary 
conserved residues of sterol reductases and exper-
imentally proved that they both failed to com-
pensate for sterol reductase deficiency in yeast. While p.R583Q 
completely failed to compensate, p.N547D could partially 
restore C14 sterol reduction, but produced a huge amount of 
abnormal metabolites. The relevant functional effect is under-
scored by the fact that mutations in homologous positions in 
another human sterol reductase, 7-dehydrocholesterol reductase 
[DHCR7 (MIM 602858)], cause Smith-Lemli-Opitz syndrome 
[SLOS (MIM 270400)].6,32 Smith-Lemli-Opitz syndrome is a 
recessive disease with multiple malformations including skeletal 
and developmental defects, and mental retardation.33,34 Notably, 
an abnormal sterol metabolite is also found in the same pathway 
where LBR is expected to function; whereas LBR acts in an ear-
lier step in cholesterol synthesis, DHCR7 catalyzes the final con-
version from 7-dehydrocholesterol to cholesterol (overview in 
Fig. 7, reviewed in ref. 26). The lamin B receptor mutation LBR.
N547D corresponds to a mutation found in Smith-Lemli-Opitz 
syndrome affecting residue DHCR7.N407Y.32 Mutation LBR.
R583Q has a homolog DHCR7 mutation with even an identi-
cal amino acid exchange from arginine to glutamine (DHCR7.
R443Q).6 We excluded mutations in DHCR7 and TM7SF2 in 
all three of our families. Thus, both LBR missense mutations 
Discussion
We studied three cases of Greenberg dysplasia in which LBR 
missense and nonsense mutations were identified. There was no 
phenotypic difference between fetuses with nonsense and mis-
sense mutations. Both missense mutations changed evolutionary 
conserved residues of the sterol reductase domain and failed to 
rescue sterol reductase deficient yeast. We showed that carrying 
a heterozygous missense mutation affecting the sterol reductase 
domain did not alter nuclear shape in neutrophils. We demon-
strated LBR expression in cytoplasmatic compartments (ER) and 
in embryonic structures essential for bone development. Our 
findings uncouple the metabolic from the structural function of 
LBR and indicate that the developmentally essential enzymatic 
function may be exerted in the ER.
LBR is a hybrid protein, is likely to mediate separate func-
tions and thus could also contribute to separate distinct dis-
eases. LBR is the only sterol reductase that gained an additional 
200 amino acids at the N-terminus which added new functions 
such as the localization to the nucleus and interaction with chro-
matin and other nuclear components.1-7 The combination of an 
Figure 4. Localization of the lamin B receptor in human control fibroblasts. (A) Lamin B re-
ceptor staining (gp-anti-LBR_N-term) of the nuclear rim and in addition in the cytoplasm 
in control fibroblasts. The non-nuclear LBR showed a partial co-localization with the ER 
membrane protein calnexin (green), indicating a localization of LBR in this compartment. 
Scale bar 10 µm. (B) Nuclear (N) and cytoplasmatic (C) extracts from human control skin 
fibroblasts showed a strong LBR expression in both the nuclear and the cytoplasmatic 
fraction by three different LBR antibodies. The nuclear protein lamin B2 and the cytoplas-
matic alpha tubulin confirmed separation of the nuclear and cytoplasmatic fractions.
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(MIM 302960)], lathosterolosis [MIM 607330], desmosterolo-
sis [MIM 602398] and Smith-Lemli-Opitz syndrome all have 
defects in enzymes of the cholesterol synthesis pathway down-
stream of LBR (Fig. 7). Skeletal defects, complete or increased 
prenatal or perinatal lethality and dysmorphic facies are present 
in all these conditions (reviewed in ref. 26). The results presented 
here fit with the view that the enzymopathy in LBR deficiency 
is causative for Greenberg dysplasia and thus indeed belongs to 
appear to result in functional null effects with respect to sterol 
metabolism.
The relevance of the metabolic function of LBR for 
 Greenberg dysplasia is underscored by a phenotypic and 
pathogenic overlap with other diseases associated with choles-
terol synthesis in humans. The congenital hemidysplasia with 
 ichthyosiform erythroderma and limb defects [CHILD syn-
drome (MIM 308050)], chondrodysplasia punctata X2 [CDPX2 
Figure 5. Expression of the lamin B receptor in different cell types and in development. (A) Relative LBR mRNA expression in different human cell 
lines, calibrated to fibroblasts. The highest expression is found in cell types associated with skeletal development, consistent with the most obvious 
manifestations in Greenberg dysplasia. Analyzed cell types: Skin fibroblasts (HAF), breast cancer cells (MCF-7), lymphoblastoid cells (LCL), lung cancer 
cells (A549), cervical cancer cells (HeLa), in-vitro differentiated osteoclasts (OC) and osteosarcoma cells (HOS). (B) Lbr expression in mouse tissues from 
developmental stage P4, calibrated to liver. Lung, skin and bone show the highest Lbr expression which is consistent with the main manifestation sites 
in patients with Greenberg dysplasia. (C) In-situ hybridization of Lbr in day 12.5 mouse embryos. Pronounced expression is found in liver, in several 
regions of the brain, in skin, developing incisors, in midgut epithelium, lung epithelium and in vertebral condensations. Mouse embryonic day E12.5 
corresponds to human gestational week 8 + 2 (post menstruation). Scale bar 500 µm.
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abnormal metabolite, cholesta-8,14-dien-3β-ol, may mediate 
toxic effects. Alternatively, upstream or downstream interme-
diates in cholesterol metabolism that are altered in quantity or 
the metabolic malformation syndromes.26 Detailed mechanistic 
information is not yet available how the loss of sterol reductase 
activity of the lamin B receptor causes Greenberg dysplasia. The 
Figure 6. Expression analysis of Lbr protein in wildtype mouse fore limb on embryonic day E15.5. (A) Lbr (red) is strongly expressed in skin and in 
growth plate cartilage with exception of the hypertrophic zone. Immunostaining for the cartilage marker Sox9 (green) is shown for comparison. Posi-
tive staining is also detected in skin, muscle cells and connective tissue fibroblasts. In the region of the cortical bone, osteoblasts show a specific Lbr 
staining in higher magnification. DNA was stained by DAPI (blue). (Note that the bright Lbr and Sox9 staining at the diaphysic bone collar is an artifact 
due to unspecific antibody binding to the bone matrix). Scale bars: 5x and 20x 100 µm, 63x 50 µm. (B) Cytoplasmatic staining in chondrocytes and con-
nective tissue fibroblasts. White arrowheads point to cytoplasmatic LBR staining in chondrocytes, grey in connective tissue fibroblasts. Magnification 
from (A) 63x cartilage. Scale bar 25 µm.
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Figure 7. Cholesterol synthesis pathway, associated diseases and putative pathogenic mechanisms (reviewed in refs. 26, 49 and 50). Blockade of 
the C14 sterol step might lead to an accumulation of precursors with subsequent up or downregulation. This accumulation could affect important 
pathways such as farnesylation, heme and ubiquinone synthesis, or even the first hydroxyl methyl glutaryl CoA reduction step. Equally or more likely 
might be a deficiency in downstream products. LBR catalyzes an early step in post-squalene cholesterol synthesis. Failure in this step might subse-
quently result in different amounts or composition of derivates from intermediate steps, such as meiosis activating sterols, oxysterols, vitamin D, and 
finally of the end-product cholesterol and its derivates bile acids and steroid hormones.26 Cholesterol is a major component of membranes and lipid 
rafts and is produced in significant amounts by the fetus itself.51 Insufficient amounts and altered membrane composition could impair fetal develop-
ment. Greenberg dysplasia could even feature a modified hedgehog pathway, as a result of cholesterol modification. Hedgehog proteins are modified 
by cholesterol.52 Altered hedgehog signaling was shown in other diseases of the post-squalene pathway35 and mutations in genes of the hedgehog 
pathway cause a number of skeletal defects. These defects include brachydactyly and polydactyly that are also seen in Greenberg dysplasia. Impaired 
vitamin D metabolism might be another potential effector in Greenberg dysplasia since LBR affects a step upstream of the vitamin D precursor 
7-dehydrocholesterol. Vitamin D is essential for bone development. Vitamin D is produced in significant amounts in the placenta and the fetus itself. 
Though to our knowledge, whether or not there is de novo synthesis of vitamin D in the fetus is not entirely clear; however, at least locally such syn-
thesis might be possible. There are overlapping pathophysiologic and histologic findings in Greenberg dysplasia, rickets in children, and osteomalacia 
in adults. Skeletal mineralization depends on the presence of sufficient amounts of calcium and phosphate at the sites of mineralization. Furthermore, 
chondrocytes, osteoblasts and collagen matrix must position and function properly. Mineralization occurs in chondrocytes. If osteoblasts produce 
more matrix than the chondrocytes can mineralize, rickets or osteomalacia can develop. Similar mechanisms could be operative in a very early stage 
of skeletal development in Greenberg dysplasia. The imbalance could either be due to absence or mal-position of calcium by vitamin D deficiency or 
by abnormal chondrocyte function. In addition, rickets show inadequate mineralization of the chondrocyte matrix in the growth plates. In both rickets 
and Greenberg dysplasia there is a disorganization or complete failure of chondrocytes to form chondrocyte columns. Epiphyses are stippled, growth 
of long bones is impaired in both conditions. Osteomalacia is also seen in neurofibromatosis and as a complication of anticonvulsive therapy.53
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might enable survival. We described a patient earlier with a 
homozygous LBR mutation, IVS12-5-10del, where the intronic 
deletion almost completely abolished normal splicing with sub-
sequent skipping of exon 13, frameshift, and a premature stop 
codon.15 However, the splicing defect was not complete. Trace 
amounts of normally spliced mRNA and normal protein could 
be shown. This patient clearly had homozygous Pelger manifes-
tations with round neutrophil nuclei, indicating that there was 
an almost 100% penetrance of this mutation with respect to the 
structural function. However, with respect to sterol metabolism, 
even these tiny amounts of normal LBR seemed to have been suf-
ficient to permit survival. This patient had mild mental retarda-
tion, brachydactyly due to shortened metacarpals, and a cardiac 
defect15 all far less severe phenotypes than observed in Greenberg 
dysplasia. The findings in this Pelger patient and the presented 
Greenberg cases suggest that minimal amounts of functional 
LBR are essential for human fetal development and survival.
Complete loss of LBR is lethal in humans but not necessarily 
in mice. Lbr deficiency in mice (ic/ic) presents with severe skin 
alterations (alopecia and ichthyosis), a Pelger blood phenotype, 
growth deficit, increased perinatal death, variable syndactyly, 
and hydrocephalus.7,17,40 Wassif et al. analyzed sterol metabolism 
in Lbr deficient mice bred on different backgrounds and identi-
fied a sterol defect only on specific backgrounds and at a defined 
point of development in the brain.27 They concluded that the 
phenotype in Greenberg dysplasia and ichthyosis is more likely 
to be caused by altered nuclear structure than by sterol metabo-
lism. Based on our finding that LBR missense mutations affected 
the sterol metabolism but not the nuclear morphology and that 
no additional mutation in DHCR7 or TM7SF2 were found, we 
conclude that in humans the sterol defect of the lamin B receptor 
is pathogenic for Greenberg dysplasia.
Manifestations in response to homozygous failure of the 
lamin B receptor differ between species. Complete lamin 
B receptor deficiency seems to be not compatible with life in 
humans, shows a severe phenotype in mice but is tolerated by 
Drosophila.41 Drosophila Lbr is evolutionary not highly conserved 
and lacks sterol reductase activity,41 probably because cholesterol 
is an essential nutrient in flies not requesting an endogenous 
cholesterol synthesis. There is no explanation yet for the differ-
ent phenotypes of LBR deficiency in man and mice; hypotheses 
include variations in cholesterol synthesis, transport or placental 
transfer. Phenotypic differences between human and mice are 
also seen in defects of other components of cholesterol synthe-
sis. Thus, 3β-hydroxysteroid dehydrogenase defects cause limb 
defects in humans (CHILD syndrome) but not in Bpa mice.26
In humans, the fetal deaths in Greenberg dysplasia and severe 
skeletal defects in other cholesterol synthesis disorders underscore 
the importance of normal sterol synthesis for intrauterine devel-
opment. This is of relevance for considering potential teratogenic 
side effects of lipid lowering drugs but also of antimicrobial agents 
that often target sterol synthesis.42-45
We conclude that LBR missense mutations in the transmem-
brane domain can abolish sterol reductase activity, thereby caus-
ing lethal Greenberg dysplasia but not Pelger anomaly. This 
finding separates the metabolic from the structural function of 
quality could affect farnesylation, oxysterols, steroid hormones, 
bile acids, vitamin D, hedgehog signaling, modification of other 
nuclear components as well as cytoplasmatic and nuclear lipid 
signaling.26,35-37 These effects and alteration of the structural and 
metabolic function of cholesterol itself are all possible partici-
pants in the disease process.
The other sterol reductases of the postsqualene synthesis 
reside and act in the cytoplasm. We showed that the lamin B 
receptor is not only present in the nucleus but also exhibits an 
extensive presence in cytoplasmatic structures. The lamin B 
receptor has been so far viewed as a protein of the inner nuclear 
membrane. In contrast, fibroblasts showed in addition to the 
nuclear localization an extensive lamin B receptor staining in 
cytoplasmatic compartments (shown for three different LBR 
antibodies). This could either be due to a functional demand of 
cholesterol synthesis in certain cell types. Alternatively, cells with 
higher LBR expression levels might exceed the nuclear binding 
capacity for the lamin B receptor.38 However, the abnormal sterol 
metabolite in Greenberg dysplasia was initially identified in fibro-
blasts that were grown in lipid depletion, forcing endogenous 
cholesterol synthesis.18 Since fibroblasts show both this feature 
of sterol synthesis and this exceptional extranuclear localization 
of LBR, the lamin B receptor is likely to participate in cytoplas-
matic cholesterol synthesis. Further, we demonstrated partial co-
localization with the endoplasmatic reticulum membrane-protein 
calnexin. These findings are in agreement with the cytoplasmatic 
localization of other sterol reductases and the endogeneous cho-
lesterol synthesis in the ER.5 LBR localized to cytoplasmatic 
structures in significant amounts especially in certain cell types 
such as skin fibroblasts and bone-related cells, indicating the 
potential and probably the in vivo need for a de-novo endoge-
neous sterol synthesis.
We further showed that LBR is expressed in critical times 
and tissues of prenatal development in mice, corresponding 
to the predominant phenotypic defects skeletal dysplasia and 
edema seen in Greenberg fetuses. At mouse embryonic day 12.5 
and 15.5 Lbr is present at RNA or protein level, respectively, in 
skin, epithelia of lung and midgut, liver as the organ of major 
fetal hematopoiesis but also in brain and distinct regions of skel-
etal development. Lbr expression in cartilage is pronounced in 
all growth plate chondrocytes and also present in osteoblasts 
forming the primary cortex. This is consistent with the histo-
logic changes in bones from Greenberg fetuses such as disorga-
nization or lack of chondrocyte columns, lack of growth plates, 
abrupt transition from cartilage to bone and premature exces-
sive ossification of the diaphysic bone collar. These histologic 
changes were found, to our knowledge, in all histologically ana-
lyzed fetuses with Greenberg dysplasia,18,19,21-25,28,39 and were also 
found in our fetuses. The expression pattern we document for 
the embryonic and postnatal mouse in combination with our 
finding that human osteoclasts and osteoblast-like cells (HOS) 
also strongly express LBR, indicate that the lamin B receptor is 
involved in cartilage and bone development in both human and 
mouse.
Complete loss or functional loss of LBR as a sterol reductase 
is developmentally lethal in humans whereas trace amounts 
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described.15 Human wildtype LBR and both mutants showed the 
same expression pattern in western blot indicating that transfec-
tion efficiency was comparable (data not shown).
Used LBR antibodies. The most widely used LBR anti-
body, the guinea pig polyclonal anti-LBR antibody (gp-anti-
LBR_N-term) is directed to the first 210 aminoacids of LBR 
and was kindly provided by Harald Herrmann-Lerdon.15 The 
specificity of this antibody was shown in Shultz and co-workers: 
Immunostaining and immunoblot of Lbr deficient cells showed 
no background staining by the LBR antibody.17 The rabbit mono-
clonal anti-LBR antibody (rb-anti-LBR_N-term) is also directed 
against the N-terminus of human LBR (Epitomics, Burlingame, 
CA, catalogue number 1398-1). The mouse monoclonal anti-
LBR antibody (mouse-anti-LBR_C-term) is directed against the 
C-terminal domain of LBR (klh-19, kindly provided by Harald 
Herrmann-Lerdon).
Immunostaining in human fibroblasts. Human dermal fibro-
blasts were cultivated in Dulbecco’s Modified Eagle Medium 
(Lonza, Basel, Switzerland) with 10% fetal calf serum (FCS) 
and 2 mM L-glutamine. Cells were grown on coverslips, fixed 
in 4% paraformaldehyde in 1x phosphate buffered saline (PBS) 
for 10 min at 4°C, then blocked for 30 min with 10% bovine 
serum albumine (BSA) in PBS, incubated for 1 h with poly-
clonal gp-anti-LBR_N-term (1:100 dilution) followed by an 1 h 
incubation with the secondary antibody (Alexa 555-conjugated 
goat anti-guinea pig antibody, Molecular Probes, 1:1,000) and 
DAPI (Sigma, 1:1,000). Cells were mounted with Fluoromount 
G (SouthernBiotech) and imaged using an LSM 510 meta 
microscope (Carl Zeiss, Göttingen, Germany) with a x63 Plan 
Apochromat oil immersion objective.
Nuclear extraction and immunoblotting. Nuclear and 
cytosolic fractions of whole cell lysates of skin fibroblasts were 
extracted by the Nuclear-Extraction Kit (Cayman Chemicals) 
and resolved by electrophoresis in SDS poly-acrylamide gels. 
The following antibodies were used for immunoblot analysis on 
PVDF membranes: as described above the polyclonal gp-anti-
LBR_N-term, monoclonal rb-anti-LBR_N-term, monoclonal 
mouse-anti-LBR_C-term, further a rabbit polyclonal calnexin 
antibody (catalogue number GTX13504, Acris Antibodies, 
Herford, Germany), a mouse monoclonal alpha-tubulin anti-
body (ab7291, abcam, Cambridge, USA), and a mouse mono-
clonal anti-lamin B2 antibody (clone X223, catalogue number 
65147C, Progen, Heidelberg, Germany). All immune reactions 
were carried out in 10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 
0.05% Tween-20 (TBST) with 5% dried milk at RT with wash-
ing steps in TBST.
Quantitative PCR (qPCR). We studied LBR mRNA levels in 
different human cell lines and mouse tissues from postnatal day 
four. Following lysis with Trizol® and standard phenol/chloroform 
RNA extraction, total cDNA was transcribed by RevertAidTM H 
Minus First Strand cDNA Synthesis Kit (Fermentas). For qPCR 
on ABI Prism 7500 (Applied Biosystems Foster City US) we 
mixed cDNA, CyberGreen (Invitrogen), and primers. We ana-
lyzed the data using the ABI Prism SDS Software package (∆∆Ct 
method, normalisation against GAPDH). Primer sequences are 
available on request.
LBR and indicates that its sterol reductase function is essential 
for intrauterine development in humans.
Material and Methods
Patients. We studied three fetuses with the clinical diagnosis of 
Greenberg dysplasia. The Charité University Medicine ethics 
committee approved the study. Written, informed consent was 
obtained from all participants or their legal representatives. Sterol 
analyses for cholesta-8,14-dien-3β-ol was performed from fetal 
material (liver or muscle) as published in Offiah et al.25
Sequence analyses. We sequenced all exons including the 
flanking intron regions of the LBR gene (NM_002296.2) as 
described previously15 in either the fetus or the parents as obli-
gate heterozygous carriers. All mutations were tested for correct 
segregation in the patient’s families (where available). We fur-
ther analyzed 300 control chromosomes to exclude a previously 
undescribed polymorphism. To explore the functional effect of 
missense mutations, we proved the evolutionary conservation of 
the affected residues by BLAST alignment and interspecies com-
parison. We sequenced additionally all coding exons of the genes 
encoding the two other members of the C14 sterol reductases fam-
ily, DHCR7 (NM_001360.2) and TM7SF2 (NM_003273.2), 
respectively. Primer sequences are available on request.
C14 deficient yeast complementation assay. C14 sterol reduc-
tase deficient yeast has a defect of ERG24, resulting in abnor-
mal sterol metabolism and consequent failure to grow (Suppl. 
Fig. 2). ERG24 belongs to the same C14 sterol reductase fam-
ily as the lamin B receptor. Human wildtype LBR rescues the 
ERG24 deficiency in yeast.5,30 We therefore tested whether or not 
human LBR carrying the missense mutations rescued the yeast 
phenotype.
Vectors p1023 (hsLBR_wt) and p1032 (empty) were kindly 
donated by Gerard Loison. We introduced the missense muta-
tions p.N547D and p.R583Q by mutagenesis following the 
manufacturer’s instructions (QuikChangeR XL Site-directed 
Mutagenesis Kit, Stratagene). ERG24, wild type LBR, LBR_
N547D and LBR_R583Q were each cloned in the yeast expres-
sion vector pEMR1032. We performed all analyses under the 
control of two different promoters (PGK1 and TP1) to ensure 
that the rescue deficit of mutants is not due to chance variations 
in vector  insertion or promoter activity.
ERG24 deficient yeast Saccharomyces cerevisiae BY4742erg24 
(Y11164) and the corresponding reference strain S. cerevisiae 
BY4742 (Y10000) were obtained from Euroscarf (Frankfurt, 
Germany). Transformation, expression and sterol analysis in 
yeast were performed as previously described.30,46 We replicated 
all measurements in at least two independent experiments and in 
2 different colonies per transformation.
To confirm expression of LBR in the yeast transformants we 
prepared 1 ml from log phase cultures. We pelleted ∼3 x 108 
cells, resuspended in 100 µl distilled water, added 100 µl 0.2 M 
NaOH and vortexed for 5 min at room temperature. We pelleted 
the solution at 14,000 rpm for 2 min and resuspended in 50 µl 
2x LDS buffer with 10% β-mercaptoethanol. After boiling for 
3 min and pelleting, the samples were processed as previously 
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In-situ hybridization. We generated probes for Lbr by 
RT-PCR from mouse E14.5 whole cDNA. Primer sequences 
are available on request. Antisense riboprobes were transcribed 
with SP6 or T7 polymerase using the Roche Dig-RNA labeling 
kit according to the manufacturer’s instructions. Protocols for 
whole-mount in-situ hybridizations and in-situ hybridizations on 
paraffin sections have been previously described.47,48
Immunostaining in mouse embryos (paraffin sections). For 
immunostaining, paraffin sections were deparaffinized, rehy-
drated and boiled for 10 minutes in 0.01 M Sodium citrate pH 6.0. 
Sections were blocked in 10% goat serum for 1 h, primary antibod-
ies (1:100 polyclonal guinea pig anti-LBR_N-term, generated by 
Monika Zwerger, initially described in;40 1:100 rabbit anti-Sox9, 
Santa Cruz) were applied in 5% goat serum at 4°C over night. 
Secondary antibodies (goat anti-guinea pig-Alexa Fluor 546, goat 
anti-rabbit Alexa Fluor 488, Molecular Probes, 1:1,000, together 
with DAPI, 1:2,000) were applied for 1 h at room temperature. 
Sections were analyzed using an Axiovert 200 (Zeiss) equipped 
with ApoTome optical section device and AxioVision software.
Web Resources
1. Basic Local Alignment Search Tool (BLAST), http://blast.ncbi.
nlm.nih.gov/Blast.cgi
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